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ABSTRACT Neutrophil activation plays integral roles in host tissue damage and resistance to infectious diseases. As glucose
uptakeandNADPHavailability are required for reactive oxygenmetabolite production by neutrophils,we tested thehypothesis that
pathological glucose levels ($12 mM) are sufﬁcient to activate metabolism and reactive oxygen metabolite production in normal
adherent neutrophils. We demonstrate that elevated glucose concentrations increase the neutrophil’s metabolic oscillation
frequency and hexose monophosphate shunt activity. In parallel, substantially increased rates of NO and superoxide formation
were observed. However, these changes were not observed for sorbitol, a nonmetabolizable carbohydrate. Glucose transport
appears to be important in this process as phloretin interferes with the glucose-speciﬁc receptor-independent activation of
neutrophils. However, LY83583, an activator of glucose ﬂux, promoted these changes at 1 mM glucose. The data suggest that at
pathophysiologic concentrations, glucoseuptakebymassaction is sufﬁcient to activate neutrophils, thus circumventing the normal
receptor transduction mechanism. To enable us to mechanistically understand these dynamic metabolic changes, mathematical
simulations were performed. A model for glycolysis in neutrophils was created. The results indicated that the frequency change in
NAD(P)H oscillations can result from the activation of the hexose monophosphate shunt, which competes with glycolysis for
glucose-6-phosphate. Experimental conﬁrmation of these simulations was performed by measuring the effect of glucose concen-
trations on ﬂavoprotein autoﬂuorescence, an indicator of the rate of mitochondrial electron transport. Moreover, after prolonged
exposure to elevated glucose levels, neutrophils return to a ‘‘nonactivated’’ phenotype and are refractile to immunologic stimula-
tion.Our ﬁndings suggest that pathologic glucose levels promote the transient activation of neutrophils followedby the suppression
of cell activity, which may contribute to nonspeciﬁc tissue damage and increased susceptibility to infections, respectively.
INTRODUCTION
Glucose is required for the survival, proliferation, and func-
tions of most mammalian cells. In contrast to bacteria, which
actively take up glucose to overcome high concentration
gradients, mammalian cells take up glucose passively via
facilitated diffusion. Human neutrophils, a type of terminally
differentiated peripheral blood cell, utilize glucose for the
housekeeping functions of glycolysis, and for activation of
the hexose monophosphate shunt (HMS), which is necessary
to generate large quantities of reactive oxygen metabolites
(ROMs). Glucose uptake is required for superoxide anion
production by neutrophils (1–3). Glucose is ﬁrst metabolized
by hexokinase to form glucose-6-phosphate, which can enter
glycolysis or the HMS. The HMS is the primary source of
NADPH, which, in turn, is used by the NADPH oxidase to
produce superoxide anions (4). Most of the superoxide goes
on to form other ROMs, including H2O2, hydroxyl radicals,
and HOCl. The production of reactive nitrogen species
(RNS) begins with the NO synthase, which also requires
NADPH from the HMS. This enzyme produces NO, which,
in combination with ROMs, produces peroxynitrite (5).
Glucose metabolism leading to the production of ROMs and
RNSs is therefore an important factor in host defense against
infections, although it may also contribute to the host’s col-
lateral tissue damage.
As glucose is taken into cells by facilitated diffusion,
heightened extracellular glucose concentrations will increase
intracellular levels and may thereby nonspeciﬁcally stimu-
late neutrophil metabolism, and such changes may perturb
normal biochemical pathways. For example, the elevated
serum glucose levels associated with diabetes could inﬂu-
ence neutrophil function. Unfortunately, apparently incon-
sistent results have been reported. Several reports indicate a
signiﬁcant decrease in the respiratory burst of normal neutro-
phils during exposure to $12 mM (6). On the other hand,
others have reported that unstimulated leukocytes from dia-
betic patients produce enhanced levels oxidants (7). Fur-
thermore, upon stimulation, diabetic neutrophils or diabetic
levels of extracellular glucose lead to enhanced levels of
superoxide production (8,9). It has also been reported
that neutrophils from poorly controlled diabetics exhibit
aberrant chemotaxis, bacterial killing, leukotriene produc-
tion, lysosomal enzyme release, proinﬂammatory cytokine
expression, respiratory burst, and superoxide production
(10–27). It would seem that aberrant glucose concentrations
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affect neutrophil function, although a comprehensive model
accounting for these divergent observations has not yet
emerged.
Because infectious disease is a major contributor to the
morbidity and mortality of diabetic patients (28,29) and
impaired host defense is likely a key factor (29), a better
understanding of the mechanism of glucose-mediated recep-
tor-independent changes in neutrophil function is important.
As neutrophils damage tissues and mediate host defense
while adherent, we have studied the properties of adherent
neutrophils. Nathan (30) has shown that the phenotype of ad-
herent neutrophils differs from that of nonadherent neutro-
phils: adherent neutrophils generate far more ROMs than
their nonadherent counterparts. In this study, we show that
elevated glucose levels activate the HMS to promote ROM
production by adherent neutrophils. These experimental
studies were conﬁrmed by using computational modeling of
the underlying biochemical network. A model of neutrophil
glycolysis shows that competition for glucose-6-phosphate
by the HMS leads to the observed changes in metabolic
dynamics and mitochondrial activity. However, this effect
was limited, as longer incubation periods led to neutrophil
exhaustion, an inability to produce normal levels of ROMs.
We suggest that elevated glucose nonspeciﬁcally activates
human neutrophils, which after prolonged exposure, leads to
diminished cell function. This mechanism may contribute to
the greater risk of infectious diseases in diabetes as well as
greater oxidant stress on normal tissues.
RESEARCH DESIGN AND METHODS
Materials
Hydroethidine (HE), n-formyl-methionyl-leucyl-phenylalanine (FMLP), phlo-
retin, and LY83583 were obtained from Sigma Chemical (St. Louis, MO).
Anti-Glut1 Ab was obtained from Chemicon International (Temecula, CA).
Buffers were purchased from Life Technologies (Rockville, MD) or pre-
pared such that they could be mixed to achieve the desired concentration of
glucose.
Neutrophil isolation
Peripheral blood neutrophils were obtained from normal healthy adults using
two Ficoll-Hypaque solutions (Histopaque 1077 and 1119, Sigma Chemical)
and centrifugation. Cells were washed and resuspended in HBSS, then ex-
amined for viability using trypan blue. Viability was found to be .95%.
Hexose monophosphate shunt (HMS) activity
HMS activity was measured using previously described procedures (31–32).
Cells (;2 3 106) were incubated in a total volume of 0.8 ml in media con-
sisting of either [D-1-14C] or [D-6-14C]-labeled glucose (American Radio-
labeled Chemicals, St. Louis, MO) at 0.5 mCi/ml with 1 mM or 14 mM
glucose in PBS. The produced 14CO2 was captured in a center well
containing 0.5ml hyamine hydroxide (Research Products, Mount Prospect,
IL) and a strip of ﬁlter paper. Incubations were performed in sealed con-
tainers at 37C in a shaking water bath for 4 h. CO2 was released from the
solution by addition of 1 ml of 0.7 N trichloroacetic acid followed by
incubation for 1 h. Lastly, 3 ml of scintillation ﬂuid was added to the center
well followed by counting.
Microscopy
Cells were observed using an Axiovert ﬂuorescence microscope (Carl Zeiss,
New York, NY) with mercury illumination interfaced to a computer using
Scion image processing software (33). DIC (differential interference con-
trast) and ﬂuorescence images were collected as described previously (34,35).
A narrow bandpass discriminating ﬁlter set (Omega Optical, Brattleboro,
VT) was used with excitation at 485/22 nm and emission at 530/30 nm for
FITC, and an excitation of 540/20 nm and emission at 590/30 nm for
TRITC. Long-pass dichroic mirrors of 510 and 560 nm were used for FITC
and TRITC, respectively. TMR was detected using a 540DF20 nm and
590DF30 nm ﬁlter set with 560 long-pass dichroic mirror. HE is oxidized to
ethidium bromide, a ﬂuorescent molecule, by superoxide. Ethidium bromide
is then detected using a 540DF20nm and 590DF30nm ﬁlter set with a 560
nm dichroic mirror. The ﬂuorescence images were collected with an inten-
siﬁed charge-coupled device camera (Princeton Instruments, Princeton, NJ).
Microscopy-based oxidant assays
Since DAF-2 DA ﬂuoresces when exposed to NO (but not to peroxide or
hydrogen peroxide (36)), 2% gelatin matrices in a ﬂuid phase (at 45C) were
mixed with 15 mM DAF-2 DA then allowed to cool to a semisolid state at
37C as described (33). For ROM studies, HE was employed at 3 mM in
these matrices.
Detection of metabolic dynamics
NAD(P)H autoﬂuorescence oscillations were detected as described previ-
ously (35,37). As the autoﬂuorescence of NADH and NADPH cannot be
distinguished spectroscopically, they are referred to as NAD(P)H. NAD(P)H
autoﬂuorescence is a well-established noninvasive method to study cell and
tissue metabolism (38,39). In some cases, an LED operating at 365 nm (a
Rapp ElectroOptic) was used to minimize illumination noise (both intensity
ﬂuctuations and out-of-band light noise). For ﬂavoprotein ﬂuorescence
imaging, a ﬁlter set comprised of a 455DF70 nm excitation ﬁlter, a 520DF40
nm emission ﬁlter, and a 495 nm long-pass dichroic reﬂector was used. An
iris diaphragm was adjusted to exclude light from neighboring cells. A
cooled photomultiplier tube held in a model D104 detection system (Photon
Technology International, Lawrenceville, NJ) attached to a Zeiss micro-
scope was used. Dynamic changes in autoﬂuorescence intensity were
recorded and smoothed using Felix software (Photon Technology Interna-
tional). All experiments were conducted at 37C.
Calcium studies
Neutrophils were labeled with indo-1 (Molecular Probes, Eugene, OR), then
observed as described (40).
Computational methods
Computational modeling and simulation was done using the software
Madonna (University of California at Berkeley, Berkeley, CA) and Copasi
(EML Research, Heidelberg, Germany and VBI, Blacksburg, VA, http://
www.copasi.org). The numerical routines for integration were the Rosen-
brock and LSODA algorithms, respectively.
RESULTS
Effect of stimulus on NADPH, NO,
and O22 production
Fig. 1 illustrates the dynamic cellular responses to FMLP and
glucose-active reagents for adherent neutrophils. NADPH
oscillations, NO, and superoxide production are shown in
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columns 1, 2, and 3, respectively. In these experiments,
NO and superoxide were detected using the probes 15 mM
DAF-2 DA and 3 mM HE, respectively. Individual morpho-
logically polarized untreated neutrophils demonstrated
;20 s interval oscillations with little NO and O2 release.
However, the addition of the activator 100 nM FMLP causes
a doubling effect of the NAD(P)H oscillation frequency (Fig.
1 d) (;20–;10 s). These metabolic changes are accompa-
nied by a greater rate of NO and O2 production (Fig. 1, e and
f) compared with control conditions (row 1). On the other
hand, if cells are exposed to FMLP after treatment with
agents decreasing glucose uptake including 0.5 mM phloretin
(Fig. 1, g–i) or with 10 mg/mL anti-GLUT1 antibody (data
not shown), no change in the metabolic frequency or oxidant
production were found. Furthermore, the receptor-indepen-
dent enhancement of glucose ﬂux using LY83583 causes a
similar increase in metabolic frequency and the oxidant
release (Fig. 1, j–l). These ﬁndings are consistent with the
role of glucose inﬂux in metabolic frequency changes and
oxidant production, both of which have been associated with
HMS activation.
Effect of glucose on NADPH, NO,
and O22 production
As glucose inﬂux appears to be a key parameter in cell
activation and glucose inﬂux can be enhanced by increasing
the external glucose concentration, we assessed metabolic
and oxidative responses as a function of glucose concentra-
tion. Glucose concentration of 1 and 5 mM had no signiﬁcant
effect on NAD(P)H dynamics or oxidant release by polarized
FIGURE 1 Representative kinetic traces NAD(P)H autoﬂuorescence oscillations (column 1), NO release (column 2), and ROM production (column 3) of
human neutrophils during several experimental conditions. NO and ROM release were detected by including DAF-2DA and HE, respectively, in the
extracellular matrix. These traces show ﬂuorescence intensity (ordinate) versus time (abscissa); to conserve space, only a few oscillations are shown. Polarized
cells were studied on glass slides at 37C. Untreated cells demonstrated NAD(P)H oscillations with a period of ﬃ20 s (trace a). Low rates of NO and ROM
production were observed (traces b and c). As previously reported (33), neutrophil activation with FMLP leads to high frequency NAD(P)H oscillations (t ﬃ
10 s) (traces d–f). However, pretreatment with 0.5 mM phloretin, which reduces glucose inﬂux, blocks these increases in NAD(P)H frequency and oxidant
release (traces g–i). To further address this mechanism, we nonspeciﬁcally activated glucose transport using LY83583 (traces j–l). In this case the perturbation
in glucose transport directly led to metabolic changes and enhanced oxidant release (n ¼ 3).
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human neutrophils (Fig. 2, a–f). However, we found that
glucose concentrations of 12–15 mM, similar to hypergly-
cemic levels, promote metabolic frequency doubling and
greater ROM and NO production (Fig. 2, g–i). In contrast, 15
mM sorbitol had no effect on metabolic or oxidant oscilla-
tions. Detailed dose-response studies are given in Fig. 3,
which show that 95% of the adherent or polarized cells have
lost the resting phenotype (20-s NAD(P)H oscillations) at
20 mM glucose and display high frequency oscillations (data
not shown). This increase in frequency could be inhibited
with 0.5 mM phloretin (data not shown), suggesting a role
for glucose transporters. We conclude that heightened glucose
concentrations are sufﬁcient to activate adherent neutrophils.
Kinetics of cellular responses
We next sought to characterize the timeframe of glucose-
induced changes. The doubling effect appears in ,6 min
after glucose addition (Fig. 4), as all of cells displayed a 10-s
metabolic oscillation period. Fig. 4 also illustrates that after
2.5 h of incubation, glucose’s ability to activate metabolic
oscillations begins to rapidly decline and reaches back-
ground levels in a few hours. Importantly, these changes in
metabolic activity of the neutrophil population parallel the
changes seen after activation with 100ng/ml LPS (Fig. 4).
Effect of 14 mM glucose on HMS activity
Although several previous studies (e.g., (33–35)) have linked
10 s metabolic oscillations to activation of the HMS, we
sought to provide additional biochemical evidence for glucose-
mediated activation of the shunt. To ascertain HMS activity,
we measured the formation of 14CO2 from 1-
14C-glucose and
6-14C-glucose in the presence of 1 mM or 14 mM glucose
(Fig. 5). In this determination, the amount of 14CO2 formed
during incubation with 6-14C-glucose was subtracted from
that formed in parallel experiments from 1-14C-glucose (31).
Fig. 5 shows the HMS activity in leukocytes at two glucose
concentrations. A substantially higher level of HMS activity
is present at 14 mM glucose. Therefore, HMS activity is
upregulated by an increase in glucose concentrations.
Moreover, cells incubated with 14 mM glucose for 8 h
were refractive to FMLP-mediated activation, whereas
similarly treated cells incubated with 1 mM glucose could
be stimulated (data not shown). These ﬁndings suggest that
glucose rapidly activates neutrophils followed by a gradual
inactivation to a refractory state.
Computational modeling of neutrophil metabolism
Toenable us to better understand themechanism(s) responsible
for the metabolic changes noted in the above experiments, we
FIGURE 2 The effect of extracellular glucose concentrations on neutrophil metabolism and oxidant release. NAD(P)H oscillations, NO, and ROM
production were monitored as noted in Fig. 1. At concentrations of 1 mM and 5 mM, extracellular glucose had no effect on neutrophil properties (traces a–f).
However, in the absence of any other stimulus, 12 mM glucose triggered the activated phenotype of neutrophils as illustrated by the frequency of metabolic
oscillations (g), NO release (h), and ROM production (i).
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performed computer simulations of the metabolic system
thought to play the key role in this process.We created amodel
for the upper part of glycolysis in neutrophils based on a prior
model for pancreatic cells (41). In addition, our new model
contains a simpliﬁed term for the HMS. Key elements of the
model are summarized in Table 1 (reactions) and Table 2
(kinetic equations). The equation for hexose kinase is simpli-
ﬁed compared toWestermark and Lansner (41), neglecting the
sigmoidal behavior of this enzyme assumed for pancreatic
cells. Inclusion of such behavior does not change the compu-
tational ﬁndingsdescribed below.Thus, the kinetics is assumed
irreversible and saturated with MgATP for simpliﬁcation:
vhk ¼ Vhk 3 glcðKmhk1 glcÞ: (1)
Glucose phosphate isomerase, which is only implicitly mod-
eled in Westermark and Lansner (41), is explicitly described.
However, it is simpliﬁed to a fast equilibrium reaction:
vgpi ¼ kgpi 3 g6p kgpir 3 f 6p: (2)
Phosphofructokinase and aldolase are modeled as described
in Westermark and Lansner (41) and depicted in Table 2.
GAPDH is described as a Michaelis-Menten equation for
two substrates. In contrast toWestermark et al. (41), we do not
assume NAD1 and NADH to be constant. However, we also
assume irreversibility and a constant concentration of phos-
phate. This is a strong simpliﬁcation. However, as there is no
additional feedback on or via GAPDH, the reaction has only
limited inﬂuence on the oscillatory behavior of the system:
vgapdh¼Vgapdh gapnadðKigap3Knad1Kgap3nad1Knad3gap1nad3gapÞ:
(3)
Apart from these reactions, glucose-6-phosphate is consumed
by a simple linear term accounting for the HMS, which
produces NADPH. NAD1 is recycled from NADH by
another simple linear term. The model is truncated at this
point. This means that we do not account for all NADH
produced during glycolysis. Kinetic parameters if available
were taken from the literature. Thus, Km values for hexo-
kinase, aldolase, and GAPDH were taken from Mulquiney
and Kuchel (42), whereas Km values for PFK are close to the
values reported in Westermark and Lansner (41). Maximal
velocities and other rates were adjusted for the whole system
to maintain steady state (albeit this steady state is dynamically
instable as seen below). When computational simulations
were performed, metabolic oscillations in NAD(P)H con-
centration were seen, as shown in Fig. 6. These oscillations are
mainly due to the kinetic properties of phosphofructokinase as
proposed by many authors and described by Westermark and
Lansner (41). Hence, this model predicts oscillations similar to
FIGURE 3 Dose-response studies of the effects of extracellular glucose
concentrations on the metabolic phenotype of human neutrophils. The
percentage of cells showing a 20 s NAD(P)H oscillatory period (ordinate)
versus glucose concentration (abscissa) is shown.
FIGURE 4 Glucose-mediated metabolic activation diminishes over time.
Although all cells are initially activated by 20 mM glucose (trace a), as
judged by the frequency of metabolic oscillations, this decays over time to
reach background levels by;7 h. Similar changes were noted for LPS (trace
b), a well-known neutrophil activator. No changes were found in control
samples incubated in the presence of 1 mM glucose (trace c).
FIGURE 5 HMS activity in human neutrophils in the presence of 1 mM
and 14 mM glucose. The metabolism of 1-14C-glucose and 6-14C-glucose to
14CO2 was measured as described (27,28). The cpm of
14CO2 formed from
6-14C-glucose was subtracted from that formed from 1-14C-glucose. The
cpm (HMS activity) is listed on the graph (mean6 SE). Data were corrected
for the amount of unlabeled glucose present. Heightened extracellular
glucose substantially increases HMS activity in cells (P , 0.001 using the
paired two-tailed t-test) (n ¼ 3).
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those observed experimentally, albeit with a somewhat higher
frequency.
Several hypotheses were tested using this model to
simulate high glucose and HMS activation on metabolic
oscillations. If HMS is activated due to the cells being
exposed to high glucose accompanied by heightened glucose
inﬂux, there is substantial competition for glucose-6-phos-
phate, and the oscillatory frequency increases (Fig. 6). This
effect is observed, if the HMS is activated while the glucose
concentration is in the normal range as well as when raising
the glucose concentration to the diabetic level. Given that
the model is only semiquantitative in nature and that param-
eters, like the maximal velocity of the individual enzymatic
reactions, including the enzyme concentrations, are undeter-
mined for neutrophils, we studied the robustness of the
observed qualitative effect by varying the individual param-
eter values within the oscillatory regime displaying simple
periodic oscillations. Most parameters have no or little effect
on the frequency response as depicted in Table 3. Some
parameters are able to diminish the effect in a certain range.
However, only if the system is close to the bifurcation from
steady state to oscillations and exhibiting very low amplitude
oscillations before HMS activation, the frequency change
can be negligible or even reverted to some extent. Obviously,
such very low amplitudes are not observed experimentally.
The only exception to this is the maximal velocity of the
aldolase. This parameter exhibits a regime where the fre-
quency decreases with competing HMS. These results show
that the initially observed frequency effect is robust with
respect to most parameter changes and does not depend upon
the exact set of parameters chosen. Of course, this does not
imply that there could not be any combination of parameters
that reverts the situation more dramatically, since the above
analysis is only able to study the effect of local parameter
changes starting from one initial set of parameters. The
question whether the frequency increases or decreases with
decreased ﬂux through glycolysis seems to be tightly linked
with the nonlinear characteristics of PFK. Thus, in a com-
pletely different model for glycolytic oscillations in yeast
(43), which we studied as well, the competition for glucose-
6-phosphate by the HMS also leads to an increased oscil-
lation frequency (data not shown). Here, the characteristics
of the PFK are different from the one used in the above
model and inﬂuenced by the inhibition by ATP. This effect
might also occur in neutrophilic PFK (44) and therefore, the
qualitative result that the frequency also increases in this
model when HMS competition occurs is of interest for the
current study. However, if the sigmoidal characteristics of
TABLE 1 Reaction terms
Reaction number Simpliﬁed reaction equation Kinetics
R1 Glucose/ Glucose-6-phosphate Vhk glcðKglc1glcÞ
R2 Glucose-6-phosphate/ Fructose-6-phosphate kgpi 3 g6p kgpir 3 f 6p
R3 Fructose-6-phosphate/ Fructose-bisphosphate
Vpfk
f 6ph
ðf 6ph1Khf6p 3 ð11ðkx3 fbpÞ
hxÞ
ð11alphah3ðkx3fbpÞhxÞ
h ¼ 2:5 scorr3 fbpðKfbp1fbpÞ
R4 Fructose-bisphosphate/ 2 Glyceraldehyde-3-phosphate Vfba
fbp
ðKfbp1fbpÞ
R5 Glyceraldehyde-3-phosphate 1 NAD1/ Bisphosphoglycerate 1 NADH Vgapdh
gapnad
ðKigap3Knad1Kgap3nad1Knad3gap1nad3gapÞ
TABLE 2 Systems equations
Metabolite Right-hand side of equation
Glucose-6-phosphate R1  R2 – khms * g6p
Fructose-6-phosphate R2  R3
Fructose-bisphosphate R3  R4
Glyceraldehydes-3-phosphate 2 * R4  R5
NAD1 R5 1 knadh * nadh
NADH R5  knadh * nadh
NADPH 2 * khms * g6p  knadph * nadph
FIGURE 6 Simulated time course of NAD(P)H concentration (being the
sum of NADH and NADPH). At t ¼ 200 s, the HMS is activated from 0 to
khms ¼ 0.5/s. Parameters: Vhk ¼ 179 mM/s; Kglc ¼ 47 mM; kgpi ¼ 1800/s;
kgpir ¼ 2100/s; Vpfk ¼ 2220 mM/s; Kf6p ¼ 3400 mM; kx ¼ 2/mM; hx ¼
2.5; alpha ¼ 5; scorr ¼ 1.5; Kfbp ¼ 5 mM; Vfba ¼ 220 mM/s; Vgapdh ¼ 1100
mM/s; Kigap ¼ 3210 mM; Knad ¼ 50 mM; Kgap ¼ 98 mM; knadh ¼ 16.8/s;
and knadph ¼ 15/s. Initial concentrations: glc ¼ 5000 mM; g6p ¼ 37 mM;
f6p ¼ 12 mM; fbp ¼ 2 mM; gap ¼ 1 mM; nadh ¼ 70 mM; nad ¼ 30 mM;
and nadph ¼ 1 mM.
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PFK are heavily altered, e.g., by neglecting FBP inﬂuence in
the above-described model, the model will not show the
increase in frequency and even exhibit reverse behavior.
Therefore, and as described below, our predictions have to
be veriﬁed experimentally. As a summary of our computa-
tional studies, we conclude that the change in frequency
observed could be due to a lack of glucose-6-phosphate
available to enter glycolysis as a result of competition from
the HMS upstream.
Calcium oscillations are not responsible for
glucose-mediated metabolic changes
As calcium oscillations increase in frequency during cell
activation (45), calcium might drive the metabolic oscillations
toward higher frequencies independent of cell metabolism. To
test this mechanism, calcium and NAD(P)H concentrations
were measured simultaneously (Fig. 7). When neutrophils are
exposed to a high concentration of glucose, the frequency of
their metabolic oscillations change ﬁrst, which is followed by
a change in the frequency of their calcium oscillations second.
On the other hand, if the calcium signal changed ﬁrst, then it
should have approached the back of the preceding metabolic
oscillation, not the metabolic oscillation approaching the back
of calcium signal. As the order of frequency increase could be
dependent upon the timing of glucose addition relative to the
phase of intracellular oscillators, we also applied glucose at
other points in the oscillatory metabolic cycle with identical
results (data not shown). Thus, in this case, metabolism seems
to drive calcium oscillations by a yet unknown mechanism
and the decreased ﬂux through glycolysis is apparently the
major cause for the frequency change.
Response of mitochondrial ﬂavoproteins
to glucose
We next performed experiments to verify or falsify the
somewhat counterintuitive modeling prediction that increas-
ing glucose concentrations result in a decreased ﬂux through
glycolysis. To do this, we measured the autoﬂuorescence of
ﬂavoproteins in neutrophils both before and after glucose
exposure. In neutrophils, ﬂavoproteins are found in mito-
chondria (a-lipoamide dehydrogenase and the electron
transport dehydrogenase) and within a small subpopulation
of granules containing the NADPH oxidase (46). As the
amount of ﬂavoprotein autoﬂuorescence is inversely related
to electron transport rate (47), it can be used as an indicator
of metabolic activity. Fig. 8 shows representative traces of
ﬂavoprotein intensity versus time derived from individual
neutrophils. In Fig. 8 A, 14 mM glucose was added at the
indicated time point. The ﬂavoprotein autoﬂuorescence
brieﬂy dips, suggesting an increase in electron transport
activity, then rises abruptly to a new steady-state level. The
increase in the steady-state autoﬂuorescence level reﬂects a
decrease in mitochondrial activity. As a negative control, 14
mM sorbitol was added at the indicated time point in Fig. 8 B
while the glucose concentration remained constant. In this
case, the ﬂavoprotein autoﬂuorescence level remained con-
stant, indicating that the glucose effect could not be accounted
for by some nonspeciﬁc effect, such as osmotic pressure, on
cell metabolism. Hence, mitochondrial metabolic activity is
reduced by these pathophysiologic glucose levels.
If the reduction in mitochondrial activity is due to acti-
vation of the HMS, it should be possible to reconﬁrm our
ﬁndings by normalizing metabolic activity by treating cells
TABLE 3 Robustness analysis
Parameter Range
Vhk a.b. 160–190
Kglc 0–900 a.b.
kgpi 1400–2400 s.a.
kgpir s.a. 1000–2600 a.b.
Vpfk s.a. 1700–16,000 s.a.
Kf6p 1800–4200 a.b.
kx a.b. 1–5.6
hx 0.5–3.9 a.b.
alpha 3.5–7.9 s.a.
scorr s.a.1.3–1.4 and 1.5–2.4 s.a.
Kfbp a.b. 2.8–6.7 s.a.
Vfba 210–250 rev.
Vgapdh 800–indef.
Kigap a.b. 200–6500
Knad 0–90
Kgap 0–12,700 s.a.
knadh 7.4–90
knadph 0.1–indef.
Starting from the parameter values listed in Fig. 6, individual parameters are
changed and the range of values depicted in the table for which the system
shows simple periodic oscillations with frequency increase with competing
HMS. This effect can differ in strength. a.b. on one side of the range means
that there is an additional bifurcation on this end, whereas s.a. stands for
small amplitudes in the oscillations approaching steady state, which is not
in accordance with experimental ﬁndings. Rev. indicates a regime on this
side of the parameter range where the frequency effect is reverted.
Parameter units of mM and s.
FIGURE 7 Simultaneous measurements of neutrophil calcium spikes and
NAD(P)Hoscillations. Theﬂuorescence intensity (ordinate) is shown for a single
cell versus time (abscissa). As the excitation and emission spectra of indo-1 and
NAD(P)H are similar, the concentration of indo-1 was adjusted such that the
intensities ofNAD(P)Hoscillations and calciumspikeswere similar inmagnitude
so that a single emission channel could be used. Cells were suspended in HBSS
containing 5 mM glucose. After glucose addition, the ﬁnal concentration of
glucose was 15 mM. A deﬁnite phase relationship exists between these two
oscillators, which is perturbed immediately after glucose addition.
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with 6-AN. If cells are treated with 1 mM 6-AN for 20 min,
then observed by microﬂuorometry, a low and constant level
of autoﬂuorescence is observed (Fig. 8 C). If 14 mM glucose
is added to these 6-AN-pretreated cells, a slight reduction in
ﬂavoprotein ﬂuorescence is observed (Fig. 8 D). To follow
the acute effects of HMS inhibition, we used a higher dose of
6-AN. In Fig. 8 E, 14 mM glucose and 10 mM 6-AN were
simultaneously added to cells at the indicated time point.Under
these conditions, there is a slightdrop inautoﬂuorescence inten-
sity and the dramatic glucose-mediated increase is dramatically
blocked. In Fig. 8 Fwe changed the order of addition such that
glucosewas added ﬁrst then followed by6-AN after the change
in autoﬂuorescence intensity. As this trace shows, 14 mM
glucose (ﬁrst arrow) caused a slight dip then large increase in
intensity, that could be reduced by addition of 10 mM 6-AN at
the second point indicated on the trace. These ﬁndings further
conﬁrm that the nonspeciﬁc activation of the HMS at high
glucose levels reduces metabolic ﬂux through the glycolytic
pathway and mitochondria.
DISCUSSION
In this study, we have combined experimental and compu-
tational methods to better understand how glucose, especially
pathophysiologic glucose concentrations, affects metabolic
dynamics and cell functions of human neutrophils. Both
methods we used have conﬁrmed and extended the ﬁndings
of the other. In the absence of other biological factors, such
as receptor agonists, our results show that glucose has the
ability to activate adherent human neutrophils. At 14 mM,
glucose alone was found to be capable of:
1. Increasing the frequency of metabolic oscillations.
2. Enhancing the production of ROMs and NO.
3. Activating theHMS as judged by radiolabeled carbon ﬂux.
These effects were not observed at low glucose concen-
trations. The cellular activation found at high glucose levels
paralleled that previously observed for receptor-mediated
activation of neutrophils, such at that mediated by FMLP
(e.g., 44). The key role of glucose is consistent with earlier
ﬁndings indicating that glucose is required for the neutro-
phil’s respiratory burst (1,2) and that an upregulation of
glucose transporter activity is associated with leukocyte
activation (3). To further link these previous studies with our
own, we found that the glucose transport inhibitor phloretin
and anti-GLUT1 antibodies inhibit neutrophil activation.More-
over, an activator of glucose transport, LY83583, activates cells
FIGURE 8 Flavoprotein responses to glucose. The autoﬂuorescence of
mitochondrial ﬂavoproteins is inversely proportional to electron transport
activity. When 14 mM glucose is added to cells, the autoﬂuorescence brieﬂy
decreases in intensity, then quickly reaches a higher steady-state level (A).
Although glucose perturbed mitochondrial activity, the nonmetabolizable
sugar sorbitol at 14 mM had no effect (B). Addition of the HMS inhibitor
6-AN alone had no effect on cells (C).When 14mM glucose is added to 1 mM
6-AN-treated cells, only a small change is noted in autoﬂuorescence inten-
sity (D), which is consistent with the role of the HMS in these changes. To
conﬁrm these changes, we altered the order of addition of glucose and 6-AN.
When 14 mM glucose and 10 mM 6-AN are simultaneously added, a small
dip in ﬂavoprotein ﬂuorescence is observed followed by a return to the
pretreatment level (E). Furthermore, if 6-AN is added after the autoﬂuor-
escence stabilizes at the higher level in the presence of 14 mM glucose,
6-AN is able to dramatically reduce the intensity of this steady-state level
(F). These data suggest that greater levels of glucose reduce mitochondrial
activity.
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in the absence of a receptor agonist. As glucose enters
eukaryotic cells via facilitated diffusion, we suggest that greater
extracellular glucose concentrations lead to greater intracellular
levels of glucose and its downstream products, especially
glucose-6-phosphate. Consequently, elevated glucose concen-
trations may simply bypass the normal regulatory signaling
pathways of leukocytes that upregulates glucose transport to
nonspeciﬁcally activate the HMS and ROM/RNS production.
We have previously demonstrated that adherent neutro-
phils exhibit NAD(P)H oscillations with a period of ;20 s,
that is reduced to ;10 s in the presence of activating sub-
stances such as FMLP, LPS, interleukin-8, etc. (45). This
correlation between period and HMS activity was conﬁrmed
using inhibitors of the HMS, such as 6-AN and dexameth-
asone, which block the formation of 10 s oscillations (45,48).
However, the mechanism underlying the change in period
has remained unknown. Our computational studies now
show that the shorter metabolic oscillation period is due to
the perturbation of glycolysis caused by activation of the
HMS—speciﬁcally, the competition between glycolysis and
the HMS for glucose-6-phosphate. Therefore, the frequency
changes are not due to oscillations of the shunt, but rather by
changes in glycolysis precipitated by activation of the shunt.
When the external glucose concentration is raised, glucose
ﬂux across the plasma membrane will increase until the
glucose transporters become saturated. Although the concen-
tration of glucose is increased, this apparently does not lead to
an increased ﬂux though glycolysis as might be expected. As
our computational modeling studies indicate, the change in
frequency is likely due to a decreased rather than an increased
ﬂux through glycolysis. This is a bit counterintuitive, but easy
to understand if one assumes the competition by the HMS
to be strong enough. To test this computational conclusion,
further experiments were performed. Previous studies have
shown that the autoﬂuorescence of mitochondrial ﬂavo-
proteins is inversely proportional to rate of mitochondrial
electron transport (47). Using this approach, we have shown
that the autoﬂuorescence of neutrophils increases dramati-
cally after addition of 14 mM glucose (Fig. 8), indicating a
decrease in mitochondrial electron transport. As the NADPH
oxidase contains a ﬂavoprotein, it may be a factor in the total
ﬂavoprotein emission.However, as electron transport through
theNADPHoxidase is increased by cell activation, this would
reduce, rather than enhance, cell ﬂuorescence. Hence, the
enhanced autoﬂuorescence intensity is an underestimate of
the glucose-induced changes. We conclude that the reduction
inmetabolism predicted by the computational model has been
experimentally conﬁrmed. In addition, this is consistent with
the conjecture of Esmann (49) that a reduction in cellular ATP
levels due to a disturbance in carbohydrate metabolism takes
place. Although our computational work is relatively new in
this ﬁeld, it is particularly important because it mechanisti-
cally explained our previous work on frequency changes and
predicted our subsequent discoveries of changes in mito-
chondrial activity.
Elevated glucose concentrations were found to activate
neutrophils, which is consistent with certain earlier studies
(7–9). However, activation was not permanent. After;2.5 h,
the percentage of activated neutrophils began to fall and
reached baseline levels within 8 h. Furthermore, glucose-
exhausted neutrophils are no longer capable of becoming
activated. These ﬁndings are consistent with other work
suggesting that extended stimulation leads to a refractory
state of neutrophils (50). Our ﬁndings are also consistent
with the fact that neutrophils isolated from diabetic patients
can have an ineffective respiratory burst (6), as most of these
cells have been exposed to high levels of serum glucose for
many hours. Thus, depending upon the experimental con-
ditions, an enhancement of reduction in metabolic activity
may be observed for glucose exposure, which may account
for the variability in prior experimental results.
Our model in vitro experiments may provide clinically rel-
evant insights. The glucose concentrations we have focused
upon in these in vitro studies, 12–15 mM, correspond to the
levels of glucose found in the peripheral blood of uncontrolled
diabetics. In addition, oxidative stress, likely due to glucose, is
thought to be an important factor in tissue damage in diabetes
(51), although the mechanism responsible for this has not
been established with certainty. We propose that one avenue
of oxidant-mediated tissue damage may be the acute nonspe-
ciﬁc activation of the neutrophil’s respiratory burst. On the
other hand, prolonged incubation with glucose leads to cell
exhaustion. This, in turn, would lead to a greater risk for
infectious disease, which is observed for the diabetic patient.
We suggest that the length of time exposed to elevated glucose
plays in key role in determining the behavior of neutrophils.
Therefore, as neutrophils reach the circulation, they may be
transiently activated to cause nonspeciﬁc oxidative tissue
damage followed by a refractory phase in which they cannot
mount a normal host defense. Our experimental and compu-
tational studies have also revealed the unexpected ﬁnding that
mitochondrial metabolism is reduced at high glucose levels.
This provides another potential route involving reduced
energy resources for tissue damage during diabetes. These,
and further biophysical/clinical studies may help explain the
regulation of neutrophil activity in diabetes and control its
detrimental effects in patients.
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